Identification and synthesis of metabolites of the new 4.5-dihydroisoxazol-5-carboxamide derivate Authors
Introduction: 3-(2-butyl-5-chloro-1H-imidazole-4-yl)-N-[4-methoxy-3-(trifluoromethyl)phenyl]-4,5-dihydro-1,2-oxazole-5-carboxamide is new antirheumatic drug. It is necessary to identify and synthesize the biotransformation products for its complete pharmacokinetic study. Materials and Methods: A bio...
Saved in:
Main Authors: | Alexander L. Khokhlov (Author), Ilya I. Yaichkov (Author), Mikhail A. Alexeev (Author), Mikhail K. Korsakov (Author), Anton A. Shetnev (Author), Sergey A. Ivanovsky (Author), Nikita N. Volkhin (Author), Sergey S. Petukhov (Author), Elena A. Vasilyeva (Author) |
---|---|
Format: | Book |
Published: |
Belgorod National Research University,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification and synthesis of metabolites of the new antiglaucoma drug
by: Alexander L. Khokhlov, et al.
Published: (2024) -
Screening of anti-inflammatory activity of 4.5-dihydroisoxazol-5-carboxamide (PAR-2 inhibitors) based on formaldehyde oedema model among white lab rats
by: Mikhail K. Korsakov, et al.
Published: (2023) -
Development of quantification methods of a new selective carbonic anhydrase II inhibitor in plasma and blood and study of the pharmacokinetics of its ophthalmic suspension in rats
by: Alexander L. Khokhlov, et al.
Published: (2023) -
Study of biotransformation of new selective carbonic anhydrase II inhibitor 4-(2-methyl-1,3-oxazole-5-yl)-benzenesulfonamide
by: A. L. Khokhlov, et al.
Published: (2023) -
Through scaffold modification to 3,5-diaryl-4,5-dihydroisoxazoles: new potent and selective inhibitors of monoamine oxidase B
by: Rita Meleddu, et al.
Published: (2017)